Position in INBX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$379,000
New position
Shares Held
4,000
first reported quarter
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 161 holders
Holding Since
Jun 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACQUARIE GROUP LTD holds $47,158,112 across 21 Biotechnology names. INBX ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,980 | $18,865,804 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,532 | $10,931,901 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,943 | $6,304,471 | |
| 4 | INCY |
Incyte Corp
|
33,301 | $3,775,000 | |
| 5 | RPRX |
Royalty Pharma plc
|
41,037 | $2,300,944 | |
| 6 | EXEL |
Exelixis, Inc.
|
27,485 | $1,495,458 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,331 | $623,829 | |
| 8 | INSM |
INSMED Inc
|
5,193 | $553,677 |
All Filings in INBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,000 | 4,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||